Edwards Lifesciences comments on CMS TAVR national coverage
Edwards Lifesciences issued a statement responding to the CMS national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.